Skip to content

Comparison of clinical outcome between thoracic endovascular aortic repair with medical treatment and medical treatment alone in acute uncomplicated descending aortic dissection

Comparison of clinical outcome between thoracic endovascular aortic repair with medical treatment and medical treatment alone in acute uncomplicated descending aortic dissection : A Randomized Controlled Trial

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
TCTR
Registry ID
TCTR20161218001
Enrollment
70
Registered
2016-12-18
Start date
2014-03-03
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thoracic endovascular aortic repair (TEVAR) in the treatment of acute uncomplicated descending aortic dissection. acute uncomplicated descending aortic dissection Thoracic endovascular aortic repair

Interventions

All patients were treated with antihypertensive medications (calcium&#45
channel blockers&#44
nitroglycerin&#44
beta blockers&#44
or a combination). The initial goals for medical therapy were to reduce SBP to 100 to 120 mmHg&#44
heart rate to 60 to 70 beat per minute&#44
and to relieve pain. If chest pain was persistent&#44
a narcotic analgesic (morphine hydrochloride) was administered intravenously in all patients. ,The TEVAR will be performed within 8 to 14 days of the onset of dissection. The proximal landing zone had
medical treatment alone,TEVAR plus medical treatment

Sponsors

Faculty of Medicine, Siriraj Hospital
Lead Sponsor
Cardio&#45
Collaborator
Thoracic Surgery division
Collaborator

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: The patients who presenting with an acute uncomplicated descending aortic dissection.

Exclusion criteria

Exclusion criteria: Signs and symptoms of acute complications Malperfusion, rupture, intractable pain, uncontrolled hypertension Aortic diameter > 5.5 cm Anatomical not suitable for TEVAR aortic kinking > 75°, aortic diameter ( 42 mm.) Traumatic aortic dissection Connective tissue disease (ie. Marfan syndrome)

Design outcomes

Primary

MeasureTime frame
The freedom from all adverse events at 1 year 1 year after end of the intervention Standard follow-up clinical evaluations and CT angiography were performed at 1, 3, 6 and 12 months

Secondary

MeasureTime frame
all-cause death at 30 days and 1 year, aorta-related death and aortic remodeling 1 year after end of the intervention clinical evaluations and follow CT angiography

Countries

Thailand

Contacts

Public ContactWorawong Slisatkorn

Division of Cardio-Thoracic Surgery, Department of Surgery, Siriraj Hospital, Mahidol University

wslisatkorn@yahoo.com6689788876

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026